The drug developer halted late-stage studies of its potential COVID-19 vaccine to investigate a “potentially unexplained” illness.
The processor of debit and credit card payments reported higher volume in July and August.
The business software company gave investors a weak third-quarter earnings forecast.
The workplace messaging service reported slower billings growth during the second quarter.
The chipmaker raised its profit and revenue forecasts because of growing demand for 4G and 5G mobile products.
The chemical company gave investors an encouraging third-quarter update as construction demand benefits its polyurethanes unit.
The biotechnology company reported encouraging results from a study of a potential treatment for bipolar depression.
French luxury goods giant
© 2020 The Canadian Press. All rights reserved., source